Sign up to save your podcasts
Or
Share Episode 21: In the Clinic - Discussing bone health in prostate cancer with Dr Xue-Yan Jiang
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 21: In the Clinic - Discussing bone health in prostate cancer with Dr Xue-Yan Jiang
Send us a text
Approximately 1 in 10 metastatic prostate cancer patients develop osteoporotic fractures.
Whilst treatment for prostate cancer has meant patient are living longer we have to make sure they are also living better.
Testosterone removal, Androgen receptor targeted agents and steroids can all reduce bone strength.
We talk to Dr Xue-Yan Jiang who is part of a group preparing guidelines for bone health through the Royal College of Radiologists and British Association of Urological Surgeons.
We hope you enjoy.
View all episodes
By John McGrane & Michael RoweSend us a text
Approximately 1 in 10 metastatic prostate cancer patients develop osteoporotic fractures.
Whilst treatment for prostate cancer has meant patient are living longer we have to make sure they are also living better.
Testosterone removal, Androgen receptor targeted agents and steroids can all reduce bone strength.
We talk to Dr Xue-Yan Jiang who is part of a group preparing guidelines for bone health through the Royal College of Radiologists and British Association of Urological Surgeons.
We hope you enjoy.